Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Acorda Therapeutics Inc (NASDAQ:ACOR)

25.39
Delayed Data
As of Jun 29
 +0.08 / +0.32%
Today’s Change
23.85
Today|||52-Week Range
43.63
-40.65%
Year-to-Date

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Acorda Therapeutics Inc have a median target of 43.00, with a high estimate of 60.00 and a low estimate of 20.00. The median estimate represents a +69.36% increase from the last price of 25.39.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Acorda Therapeutics Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.20
Sales
$128.6M
Reporting Date
Jul 28

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 180.76%
 
 
 
 
 
 
Growthannually -28.85%
 
 
 
 
 
 

Sales

Growthquarterly 10.95%
 
 
 
 
 
 
Growthannually 4.79%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.